Results 51 to 60 of about 2,014 (215)

Sleep disturbance and intrusive memories after presenting to the emergency department following a traumatic motor vehicle accident: an exploratory analysis [PDF]

open access: yes, 2019
Background: Sleep disturbances are common after traumatic events and have been hypothesized to be a risk factor in the development of psychopathology such as that associated with posttraumatic stress disorder (PTSD).
Gebhardt, I.   +3 more
core   +2 more sources

Current research status of Traditional Chinese Medicine nursing for patients with sleep disorder after stroke (脑卒中后睡眠障碍中医护理技术研究现状)

open access: yes中西医结合护理
Sleep disorder is a common complication of stroke, which not only negatively affects the patients’ quality of life, but also affects the rehabilitation process of stroke disease.
HU Haixia (胡海霞)   +4 more
doaj   +1 more source

卒中后失眠的研究进展 Research Progress of Insomnia after Stroke

open access: yesZhongguo cuzhong zazhi, 2023
卒中后失眠是在卒中后首次出现并达到失眠诊断标准的一组临床综合征,与临床常见失眠相类似,主要表现为睡眠深度异常和平均每晚睡眠时间少于6 h。meta分析显示,卒中急性期、亚急性期及恢复期患者符合失眠障碍诊断标准的比例分别为32.5%、34.8%和37.1%。卒中后失眠不仅增加了卒中死亡及复发风险,而且对卒中康复与预后造成不利影响。本文对卒中后失眠的发病情况、发病机制及治疗等进行综述,以便为临床实践提供信息,并为卒中后失眠提供针对性干预治疗措施。 Abstract: Post stroke ...
杨行妹, 韩美荣, 蒋雪龙, 何忠明, 韩芳
doaj   +1 more source

Effect of dexmedetomidine on postoperative sleep quality and complications in women undergoing elective cesarean delivery [PDF]

open access: yes
Objective To evaluate the effect of dexmedetomidine on postoperative sleep quality and complications in women undergoing elective cesarean delivery.
YOU Yiying, ZHONG Weilong, WANG Yanling, LI Liping
core   +1 more source

佐匹克隆与盐酸曲唑酮治疗睡眠障碍的临床疗效观察 [PDF]

open access: yes, 2018
目的观察佐匹克隆与盐酸曲唑酮治疗睡眠障碍的临床疗效和安全性。方法将100例睡眠障碍患者采用随机数字表的方法分为治疗组50例和对照组50例。治疗组给予佐匹克隆治疗,对照组给予盐酸曲唑酮治疗。两组均为睡前30 min给药,疗程4周。比较两组临床治疗效果。结果治疗后,两种药品在延长患者总睡眠时间方面差异无统计学意义[(0.9±0.3)h比(0.9±0.7)h,P>0.05]。佐匹克隆治疗睡眠障碍的入睡时间评分低于盐酸曲唑酮[(0.5±0.2)分比(1.3±0.4)分,P0.05)。治疗组不良反应量表(TESS)
贺王伟, 黄宇, 黄峥嵘
core  

Network analysis of COVID-19-related PTSD symptoms in China:The similarities and differences between the general population and PTSD sub-population [PDF]

open access: yes, 2021
BACKGROUND AND OBJECTIVES: Prevalent Post-traumatic Stress Disorder (PTSD) negatively affected individuals during the COVID-19 pandemic. Using network analyses, this study explored the construct of PTSD symptoms during the COVID-19 pandemic in China to ...
Ahmed, Farooq   +7 more
core   +1 more source

Sleep quality and influencing factors of mariners during ocean voyages [PDF]

open access: yes
BackgroundThe average sleep quality of mariners during ocean voyages is notably worse than that of the general populace, and the incidence of sleep disorders among them is higher.
Jingru CHEN   +4 more
core   +1 more source

小儿智力糖浆治疗注意缺陷多动障碍并睡眠障碍临床评价 Clinical Observation of Xiao’er Zhili Syrup in the Treatment of Attention Deficit Hyperactivity Disorder with Sleep Disorder in Children

open access: yes, 2017
目的:观察小儿智力糖浆治疗注意缺陷多动障碍并睡眠障碍的疗效和安全性。方法:选择90例注意缺陷多动障碍并睡眠障碍患儿,随机分为治疗组与对照组,治疗组口服小儿智力糖浆,对照组服哌甲酯,疗程12周。治疗结束后采用ADHD父母评定量表(ADHD-IV Rating Scale-Parent Version, ADHDRS-IV-P)、Conners父母症状问卷(Parent Symptom Questionnaire, PSQ )和儿童睡眠状况调查问卷(Children Sleep Habit ...
吴启富, 赵宁, 匡彪
semanticscholar   +1 more source

Construction of a risk assessment model for falls in the elderly (老年人跌倒风险评估模型的构建)

open access: yes中西医结合护理, 2022
Objective To explore the establishment of a comprehensive risk assessment model for falls in the elderly people in China. Methods Meta-analysis reappraisal combined with structured expert consultation were used to screen out risk factors for falls and ...
ZHAO Dan (赵丹)   +3 more
doaj   +1 more source

尼古丁滥用与精神疾病相关睡眠障碍关系的研究综述 Review on the Association of Nicotine Abuse and Mental Disease-Related Sleep Disorders

open access: yes, 2015
烟草危害已成为我国严重的公共卫生问题之一,控制尼古丁滥用面临严峻挑战。同时,现代社会睡眠障碍的发生率越来越高,二者均已成为社会和医学共同关注的热点。大量流行病学和临床调查发现,精神疾病患者相比普通人群,具有更高的吸烟率,精神疾病与睡眠障碍之间具有紧密联系,两者具有共同的神经生物学基础。因此,探讨二者的关联对于更好地防治尼古丁滥用和睡眠障碍具有积极意义。本文就尼古丁滥用与精神疾病相关睡眠障碍之间的关系进行简要综述。 The harm of tobacco use has become one of the
贾宝福   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy